SCA
BMY icon

Sippican Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Sippican Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Hold
60,689
– – 2.13% 5
2026
Q1 		$3.68M Sell
60,689
-1,363
-2% -$79.5K 2.52% 5
2025
Q4 		$3.35M Buy
62,052
+4,000
+7% +$192K 2.15% 7
2025
Q3 		$2.62M Buy
58,052
+1,660
+3% +$77.5K 1.73% 13
2025
Q2 		$2.61M Buy
56,392
+770
+1% +$37.8K 1.9% 8
2025
Q1 		$3.39M Sell
55,622
-130
-0.2% -$7.58K 2.56% 4
2024
Q4 		$3.15M Sell
55,752
-927
-2% -$51.8K 2.3% 6
2024
Q3 		$2.93M Buy
56,679
+2,667
+5% +$125K 2.05% 11
2024
Q2 		$2.24M Buy
54,012
+11,865
+28% +$531K 1.78% 18
2024
Q1 		$2.29M Buy
42,147
+3,145
+8% +$160K 1.78% 15
2023
Q4 		$2M Buy
39,002
+6,341
+19% +$333K 1.57% 17
2023
Q3 		$1.9M Buy
32,661
+2,265
+7% +$139K 1.71% 15
2023
Q2 		$1.94M Sell
30,396
-203
-0.7% -$13.6K 1.79% 12
2023
Q1 		$2.12M Sell
30,599
-60
-0.2% -$4.23K 2.03% 9
2022
Q4 		$2.21M Sell
30,659
-152
-0.5% -$11.5K 2.11% 10
2022
Q3 		$2.19M Sell
30,811
-920
-3% -$66.7K 2.28% 5
2022
Q2 		$2.44M Sell
31,731
-2,070
-6% -$158K 2.42% 4
2022
Q1 		$2.47M Buy
33,801
+250
+0.7% +$16.8K 2.05% 6
2021
Q4 		$2.09M Buy
33,551
+1,146
+4% +$67.2K 1.78% 13
2021
Q3 		$1.92M Buy
32,405
+674
+2% +$44.4K 1.66% 16
2021
Q2 		$2.12M Sell
31,731
-924
-3% -$60.3K 1.84% 11
2021
Q1 		$2.06M Buy
32,655
+1,416
+5% +$88.1K 1.9% 9
2020
Q4 		$1.94M Sell
31,239
-1,062
-3% -$65.3K 2.1% 8
2020
Q3 		$1.95M Buy
32,301
+2,225
+7% +$134K 2.42% 6
2020
Q2 		$1.77M Sell
30,076
-2,509
-8% -$150K 2.38% 5
2020
Q1 		$1.82M Sell
32,585
-5,036
-13% -$308K 2.96% 3
2019
Q4 		$2.42M Buy
37,621
+460
+1% +$26.3K 2.69% 3
2019
Q3 		$1.88M Buy
37,161
+1,085
+3% +$51K 2.28% 5
2019
Q2 		$1.64M Buy
36,076
+2,633
+8% +$123K 1.93% 12
2019
Q1 		$1.6M Sell
33,443
-285
-0.8% -$14.2K 1.9% 14
2018
Q4 		$1.75M Buy
33,728
+46
+0.1% +$2.47K 2.37% 8
2018
Q3 		$1.78M Sell
33,682
-2,000
-6% -$119K 2.06% 10
2018
Q2 		$1.98M Buy
35,682
+9,674
+37% +$522K 1.97% 9
2018
Q1 		$1.65M Buy
26,008
+1,247
+5% +$80.2K 1.71% 17
2017
Q4 		$1.52M Buy
24,761
+3,960
+19% +$248K 1.48% 22
2017
Q3 		$1.33M Buy
20,801
+3,272
+19% +$191K 1.36% 28
2017
Q2 		$977K Buy
17,529
+1,124
+7% +$61.2K 1.06% 36
2017
Q1 		$892K Buy
16,405
+4,176
+34% +$229K 0.95% 40
2016
Q4 		$715K Sell
12,229
-1,075
-8% -$58.8K 0.75% 48
2016
Q3 		$717K Sell
13,304
-100
-0.7% -$6.42K 0.82% 44
2016
Q2 		$986K Sell
13,404
-340
-2% -$24K 1.17% 33
2016
Q1 		$878K Sell
13,744
-185
-1% -$11.7K 1.12% 37
2015
Q4 		$958K Sell
13,929
-50
-0.4% -$3.3K 1.21% 32
2015
Q3 		$828K Sell
13,979
-900
-6% -$57.1K 1.05% 37
2015
Q2 		$990K Sell
14,879
-6
-0% -$395 1% 38
2015
Q1 		$960K Hold
14,885
– – 0.98% 37
2014
Q4 		$879K Sell
14,885
-225
-1% -$12.7K 0.88% 41
2014
Q3 		$773K Buy
+15,110
New +$755K 0.79% 52

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sippican Capital Advisors's BMY Position: Q2 2026 in Review

Sippican Capital Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 60,689 shares worth $3.5M. The position accounts for 2.13% of the portfolio, ranked #5.

Sippican Capital Advisors first reported a position in BMY in Q3 2014 and has held it in 48 quarters since. The position peaked at $3.68M in Q1 2026. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Sippican Capital Advisors held 60,689 shares of Bristol-Myers Squibb worth $3.5M as of Q2 2026.
  • Sippican Capital Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 2.13% of Sippican Capital Advisors's portfolio in Q2 2026, its #5 holding.
  • Sippican Capital Advisors first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 48 quarters since.
  • Sippican Capital Advisors's Bristol-Myers Squibb position peaked at $3.68M in Q1 2026.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Sippican Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.